Recent progress in melanoma treatment is based on research that poorly represents global population diversity, with little focus on relevant subtypes for non-European and admixed populations. However, there is an opportunity to change this and contribute to a more accurate understanding of melanoma worldwide.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Ugurel, S. et al. Eur. J. Cancer 130, 126–138 (2020).
Ossio, R. et al. Nat. Rev. Cancer 17, 393–384 (2017).
Bradford, P. T. et al. Arch. Dermatol. 145, 427–434 (2009).
Alicea, G. M. & Rebecca, V. W. Nat. Rev. Cancer 22, 127–128 (2022).
Basurto-Lozada, P. et al. Pigment Cell Melanoma Res. 34, 59–71 (2020).
Krogstad, J. M. Pew Research Center https://pewrsr.ch/324NHu4 (2020).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Possik, P.A. Obstacles and opportunities in studying melanoma in Latin America. Nat Cancer 4, 777–778 (2023). https://doi.org/10.1038/s43018-023-00560-9
Published:
Issue Date:
DOI: https://doi.org/10.1038/s43018-023-00560-9